bibliographic resource 1038281 [br/1038281]
https://w3id.org/oc/corpus/br/1038281

is a
title
  • Cost-effectiveness of dapagliflozin versus DPP-4 inhibitors as an add-on to Metformin in the Treatment of Type 2 Diabetes Mellitus from a UK Healthcare System Perspective
publication date
  • 2015-01-01
citation
contributor
identifier
part of
reference